WebBIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally … WebMar 6, 2024 · BIOLASE's laser systems are designed to provide clinically superior, patient friendly results for many types of common dental procedures compared to those …
S-1
WebBiolase Inc. SEC filings breakout by MarketWatch. View the BIOL U.S. Securities and Exchange Commission reporting information. WebMar 17, 2024 · BIOL Biolase Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).. Emerging growth company ☐ tsibogang pre school
BIOLASE, Inc. (BIOL) Earnings Transcripts Seeking Alpha
WebSEC Filings. Insider Monkey. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2024 Earnings Call Transcript. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2024 Earnings Call Transcript March 28, 2024 Operator: Greetings. Welcome ... WebJun 28, 2011 · Reference is hereby made to that certain License Agreement, which is in effect having an effective date of January 1, 2009 (which superseded that certain License Agreement, with an effective date of January 24, 2007), by and between Biolase Technology, Inc. (“BIOLASE”) and The Procter & Gamble Company (“P&G”) (the … WebMar 28, 2024 · BIOLASE, INC General Corporate Statement (Form8) Accepted: March 28, 2024 at 8:06 PM UTC. Form Type: 8-K. Accession Number: 0000950170-23-010279. tsi bs-07 bead seater